Microbiotica
microbiotica.com
Actively hiring
Microbiome
Health Care
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Flerie
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Registers and programsofficial lists and records that name the company
| Legal entity | Microbiotica Limited | its site |
Founders and leadersfrom filings, registers and the company's site
Scientific Advisors InvestorsDirectorscompany's site
Backed byfrom the funds' portfolios and accelerator catalogs
Flerie Similar startupsby what they do, their industry and backers
Writing the next chapter in GI health. Vedanta is advancing first-in-class Live Biotherapeutic Products (LBP) to treat serious…
BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial…
CAMPfield Therapeutics is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor…
Lipum is a biopharmaceutical company specialized on a novel way to treat chronic inflammatory diseases.
Scioto Biosciences is a preclinical stage biotech company dedicated to innovative research and discovery in the field of microbiome…
Turn microbiome data into smarter product decisions, stronger clinical claims, and scalable personalized testing with HelloBiome.
News
Microbiome medicine moves past wellness into clinics
Microbiome medicine moves past wellness into clinics 19 May 2026 Longevity Technology View Item
Read more
Report
View Item
Microbiome medicine moves past wellness into clinics 19 May 2026 Longevity Technology
Read more
Report
Microbiotica reports positive results for MB097 in advanced melanoma
Microbiotica reports positive results for MB097 in advanced melanoma 18 May 2026 Pharma Times View Item
Read more
Report
Microbiome Therapy Could Help Drug-Resistant Melanoma Patients
Microbiome Therapy Could Help Drug-Resistant Melanoma Patients 18 May 2026 Inside Precision Medicine View Item
Read more
Report
Microbiotica reports positive results for MB097 in advanced melanoma
Data suggests microbiome co-therapy may help overcome resistance to anti-PD-1 treatment
Read more
Report
Microbiotica Announces Positive Results from its Phase 1b Trial (MELODY-1) of MB097, a Precision Microbiome Co-Therapy in Advanced Melanoma
MB097 used in combination with MSD's anti-PD-1 therapy, KEYTRUDA (pembrolizumab) Cambridge, UK - 18 May 2026: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products
Read more
Report
Cell Symposia 2026 (poster): Gut commensal bacteria, associated with clinical remission in ulcerative colitis, induce anti-inflammatory and tolerogenic pathways
View Poster (PDF)
Read more
Report
Report
Report
Microbiotica reports positive phase Ib data for live microbiome therapeutic
Microbiotica reports positive phase Ib data for live microbiome therapeutic 11 February 2026 BioWorld View Item
Read more
Report
Show more news
People
Scientific Advisors Investors
Directors
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge
United Kingdom
Registered seat